List of insiders holdings for PROGENICS PHARMACEUTICALS INC:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
Velan Capital L.P. Altiva Management Inc. VENKATARAMAN BALAJI See Explanation of Responses 10% Owner | 2020-04-15 15:15:28 | 8,011,733 0 | 8,011,733 | Form 13D |
LTE Partners LLC Melkonian Capital Management LLC LTE Management LLC Melkonian Ryan See Explanation of Responses 10% Owner | 2019-09-09 18:14:16 | 1,950,000 0 | 1,950,000 | Form 4 |
MADDON PAUL J Director | 2016-04-22 17:09:42 | 909,891 0 | 909,891 | Form 4/A |
Baker Mark Robert Chief Executive Officer | 2019-03-05 15:49:30 | 192,500 0 | 192,500 | Form 4 |
JACOBSON PAUL F Director | 2008-10-24 16:34:22 | 125,600 0 | 125,600 | Form 4 |
Nohria Virinder See Explanation of Responses 10% Owner | 2019-08-27 15:39:59 | 110,000 0 | 110,000 | Form 3 |
Summer Jeffery SVP, Digital Technology | 2018-03-02 13:57:37 | 94,875 0 | 94,875 | Form 4 |
Hirt Sheldon Executive VP & General Counsel | 2016-03-03 14:34:13 | 82,500 0 | 82,500 | Form 4 |
Fabbio Patrick CFO | 2020-03-04 16:15:02 | 82,214 0 | 82,214 | Form 4 |
Boyd Thomas A Sr. VP, Product Dev. | 2010-07-06 14:16:33 | 79,436 0 | 79,436 | Form 4 |
Youssoufian Hagop Executive Vice President R&D | 2014-03-04 15:32:51 | 66,000 0 | 66,000 | Form 4 |
Olson William C Senior VP, Research and Develo | 2013-04-08 15:58:00 | 60,000 0 | 60,000 | Form 4 |
Crowley Peter J Director | 2019-07-15 09:01:39 | 55,000 0 | 55,000 | Form 4 |
Lovallo Angelo William JR Vice President Finance | 2015-03-04 11:27:33 | 52,800 0 | 52,800 | Form 4 |
MCKINNEY ROBERT A Senior VP, CFO | 2012-03-05 14:23:58 | 50,000 0 | 50,000 | Form 4 |
YACHMETZ PHILIP K VP, General Counsel | 2004-05-05 17:18:23 | 40,696 200 | 40,896 | Form 4 |
Cooke Terence See Explanation of Responses 10% Owner | 2019-08-27 15:25:15 | 40,000 0 | 40,000 | Form 3 |
ISRAEL ROBERT J Executive Vice President, Medi | 2015-06-15 09:32:37 | 39,050 0 | 39,050 | Form 4 |
PRENTKI RONALD J President | 2005-02-17 18:27:58 | 35,672 0 | 35,672 | Form 4 |
Kremer Alton B VP, Clinical Research | 2008-04-03 17:09:57 | 28,173 0 | 28,173 | Form 4 |
KISHBAUCH MICHAEL D Director | 2019-07-15 09:02:03 | 25,000 0 | 25,000 | Form 4 |
WILLIAMS NICOLE Director | 2019-07-15 09:02:33 | 25,000 0 | 25,000 | Form 4 |
SCHEINBERG DAVID A Director | 2019-07-15 09:02:21 | 25,000 0 | 25,000 | Form 4 |
GOFF STEPHEN P Director | 2013-06-20 15:43:27 | 20,000 0 | 20,000 | Form 4 |
BAKER CHARLES A Director | 2012-06-14 14:57:15 | 10,000 0 | 10,000 | Form 4 |
BRINER KURT W Director | 2012-06-14 14:56:45 | 10,000 0 | 10,000 | Form 4 |
DALTON MARK F Director | 2011-07-06 19:01:17 | 10,000 0 | 10,000 | Form 4 |
Ferrante Karen Jean Director | 2020-06-23 16:47:07 | 0 0 | 0 | Form 4 |
Das Asha Chief Medical Officer | 2020-06-23 16:49:43 | 0 0 | 0 | Form 4 |
Osorio Benedict COO | 2020-06-23 16:49:25 | 0 0 | 0 | Form 4 |
Tenbarge Bryce SVP, Commercial | 2020-06-23 16:49:04 | 0 0 | 0 | Form 4 |
Wong Vivien EVP, Development | 2020-06-23 16:48:47 | 0 0 | 0 | Form 4 |
Mims David W. Interim CEO and Interim CFO | 2020-06-23 16:48:25 | 0 0 | 0 | Form 4 |
Ber Gerard Director | 2020-06-23 16:48:05 | 0 0 | 0 | Form 4 |
Campbell Bradley L Director | 2020-06-23 16:47:46 | 0 0 | 0 | Form 4 |
Ende Eric J Director | 2020-06-23 16:47:26 | 0 0 | 0 | Form 4 |
MacDougall Ann L. Director | 2020-06-23 16:46:47 | 0 0 | 0 | Form 4 |
Maeusli Heinz Christoph Director | 2020-06-23 16:46:24 | 0 0 | 0 | Form 4 |
Sarpangal Deepak See Explanation of Responses 10% Owner | 2019-08-27 15:29:07 | 0 0 | 0 | Form 3 |
Broadfin Healthcare Master Fund Ltd Broadfin Capital LLC KOTLER KEVIN 10% Owner | 2018-02-13 16:57:52 | 0 0 | 0 | Form 13G |